A Phase I clinical trial of novel coronavirus pneumonia (COVID-19) mRNA Vaccine (BNT162b1) in China (Q98774084)
Jump to navigation
Jump to search
clinical trial
- ChiCTR2000034825
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase I clinical trial of novel coronavirus pneumonia (COVID-19) mRNA Vaccine (BNT162b1) in China |
clinical trial |
|
Statements
Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects: A Phase I, Randomized, Placebo-controlled, Observer-blind Study (English)
0 references
SARS-CoV-2 mRNA疫苗（BNT162b1） 在中国健康人中的 安全性和免疫原性：随机、安慰剂对照、观察者盲I期研究 (Chinese)
0 references
20 July 2020
0 references
31 December 2020
0 references
144
0 references